StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
OtherAug 27, 2026, 04:24 PM

argenx SE Files Form 6-K Report

AI Summary

argenx SE filed a Form 6-K report with the U.S. Securities and Exchange Commission for the month of August 2026. This filing incorporates by reference a press release issued on August 27, 2026. The information within this report is deemed to be incorporated into the Company's existing Registration Statements on Forms S-8.